← Back to Search

Pectointercostal fascia blocks for Postoperative Pain (SPIFFY Trial)

Phase 4
Waitlist Available
Led By Wing Lam
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 6 hours for 24 hours post-operatively
Awards & highlights
Pivotal Trial
Drug Has Already Been Approved

Summary

This trial is testing if using a special technique can help heart surgery patients manage pain better and need fewer strong painkillers.

Eligible Conditions
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 6 hours for 24 hours post-operatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and every 6 hours for 24 hours post-operatively for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Opioid consumption
Secondary study objectives
ICU length of stay
Local anesthetic systemic toxicity effects
Opioid consumption in 24 hours
+3 more

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: InterventionExperimental Treatment1 Intervention
This group of patients will undergo placement of US guided pectointercostal fascia blocks.
Group II: PlaceboPlacebo Group1 Intervention
The control group patients will receive the same intraoperative analgesia management. A PIF block will not be performed, instead, a peripheral nerve block catheter will be secured to the skin surface and connected to a CADD™ pump. As the catheter is taped to the skin surface the control group patients will not be exposed to the risks of peripheral nerve block placement.

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
919 Previous Clinical Trials
431,580 Total Patients Enrolled
Wing LamPrincipal InvestigatorUniversity of Alberta
~0 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top